These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2139465

  • 1. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR, Barry JM, Alexander SR, Melvin T, Striegel J, Reller K, Henell KR, Kimball J, Funnell MB, Goldstein G.
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [Abstract] [Full Text] [Related]

  • 2. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ, First MR, Hurtubise PE, Marmer DJ, Martin DM, Mansour ME, Melvin DB.
    J Heart Transplant; 1989 May; 8(5):371-80. PubMed ID: 2529358
    [Abstract] [Full Text] [Related]

  • 3. Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function.
    Benvenisty AI, Cohen D, Stegall MD, Hardy MA.
    Transplantation; 1990 Feb; 49(2):321-7. PubMed ID: 2137654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. OKT3 rescue therapy in pancreas-allograft rejection.
    Stratta RJ, Sollinger HW, D'Alessandro AM, Pirsch JD, Kalayoglu M, Belzer FO.
    Diabetes; 1989 Jan; 38 Suppl 1():74-8. PubMed ID: 2521330
    [Abstract] [Full Text] [Related]

  • 6. Successful retreatment of allograft rejection with OKT3.
    First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, Balistreri WF, Alexander JW, Melvin DB, Fidler JP.
    Transplantation; 1989 Jan; 47(1):88-91. PubMed ID: 2521410
    [Abstract] [Full Text] [Related]

  • 7. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
    Mariat C, Alamartine E, Diab N, de Filippis JP, Laurent B, Berthoux F.
    Transpl Int; 1998 Jan; 11(3):231-6. PubMed ID: 9638854
    [Abstract] [Full Text] [Related]

  • 8. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG, O'Connell JB, Gilbert EM, Hammond ME, Burton NA, Jones KW, Karwande SV, Doty DB, Menlove RL, Herrick CM.
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [Abstract] [Full Text] [Related]

  • 9. OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejection.
    Leone MR, Alexander SR, Barry JM, Henell K, Funnell MB, Goldstein G, Norman DJ.
    J Pediatr; 1987 Jul; 111(1):45-50. PubMed ID: 3298596
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy.
    Norman DJ, Barry JM, Bennett WM, Leone M, Henell K, Funnell B, Hubert B.
    Am J Kidney Dis; 1988 Feb; 11(2):90-3. PubMed ID: 3124611
    [Abstract] [Full Text] [Related]

  • 12. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C, Rodriguez-Paternina E, Andrés A, Morales JM, Farias J, Montoyo C, Regueiro JR, Rodicio JL.
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract] [Full Text] [Related]

  • 13. Anti-rejection therapy in renal transplantation: Use of the monoclonal antibody OKT3.
    Nicholson ML, Donnelly PK, Veitch PS, Bell PR.
    Nephrol Dial Transplant; 1991 Aug; 6(4):275-9. PubMed ID: 1881582
    [Abstract] [Full Text] [Related]

  • 14. OKT3 prophylaxis in liver transplantation.
    McDiarmid SV, Millis MJ, Terasaki PI, Ament ME, Busuttil RW.
    Dig Dis Sci; 1991 Oct; 36(10):1418-26. PubMed ID: 1833167
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK, Bourge RC, White-Williams C, Naftel DC, Thomas FT, Thomas JM, Phillips MG.
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [Abstract] [Full Text] [Related]

  • 16. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation.
    Millis JM, McDiarmid SV, Hiatt JR, Brems JJ, Colonna JO, Klein AS, Ashizawa T, Hart J, Lewin K, Goldstein LI.
    Transplantation; 1989 Jan; 47(1):82-8. PubMed ID: 2521409
    [Abstract] [Full Text] [Related]

  • 17. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
    Waid TH, Lucas BA, Amlot P, Janossy G, Yacoub M, Cammisuli S, Jezek D, Rhoades J, Brown S, Thompson JS.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):61-70. PubMed ID: 2479265
    [Abstract] [Full Text] [Related]

  • 18. Recurrence of acute rejection in the absence of CD3-positive lymphocytes.
    Lazarovits AI, Shield CF.
    Clin Immunol Immunopathol; 1988 Sep; 48(3):392-400. PubMed ID: 2969787
    [Abstract] [Full Text] [Related]

  • 19. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR, Gaber AO, Haag BW, Aronson AJ, Broelsch CE, Stuart JK, Stuart FP.
    Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants.
    Mochon M, Kaiser B, Palmer JA, Polinsky M, Flynn JT, Caputo GC, Baluarte HJ.
    Pediatr Nephrol; 1993 Jun; 7(3):259-62. PubMed ID: 8518094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.